These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8617331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL, Daly TM, Long CA.
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL, Daly TM, Clynes R, Long CA.
    J Immunol; 1998 Aug 15; 161(4):1908-12. PubMed ID: 9712060
    [Abstract] [Full Text] [Related]

  • 5. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
    Kang Y, Calvo PA, Daly TM, Long CA.
    J Immunol; 1998 Oct 15; 161(8):4211-9. PubMed ID: 9780195
    [Abstract] [Full Text] [Related]

  • 6. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P, Mahakunkijcharoen Y, Kittigul L, Mahannop P, Pichyangkul S, Hirunpetcharat C.
    Clin Vaccine Immunol; 2007 Apr 15; 14(4):342-7. PubMed ID: 17314232
    [Abstract] [Full Text] [Related]

  • 7. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L, Goschnick MW, Coppel RL.
    Infect Immun; 2004 Oct 15; 72(10):6172-5. PubMed ID: 15385527
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L, Webster DE, Campbell AE, Dry IB, Wesselingh SL, Coppel RL.
    Int J Parasitol; 2008 Jan 15; 38(1):103-10. PubMed ID: 17681344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
    Shi Q, Lynch MM, Romero M, Burns JM.
    Infect Immun; 2007 Mar 15; 75(3):1349-58. PubMed ID: 17158895
    [Abstract] [Full Text] [Related]

  • 11. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM, Majarian WR, Young JF, Daly TM, Long CA.
    J Immunol; 1989 Oct 15; 143(8):2670-6. PubMed ID: 2477452
    [Abstract] [Full Text] [Related]

  • 12. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C, Vukovic P, Liu XQ, Kaslow DC, Miller LH, Good MF.
    J Immunol; 1999 Jun 15; 162(12):7309-14. PubMed ID: 10358180
    [Abstract] [Full Text] [Related]

  • 13. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
    Lozano JM, Lesmes LP, Gallego GM, Patarroyo ME.
    Mol Immunol; 2011 Jan 15; 48(4):657-69. PubMed ID: 21131051
    [Abstract] [Full Text] [Related]

  • 14. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
    Rénia L, Ling IT, Marussig M, Miltgen F, Holder AA, Mazier D.
    Infect Immun; 1997 Nov 15; 65(11):4419-23. PubMed ID: 9353014
    [Abstract] [Full Text] [Related]

  • 15. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, Miller LH, Good MF.
    J Immunol; 1997 Oct 01; 159(7):3400-11. PubMed ID: 9317139
    [Abstract] [Full Text] [Related]

  • 16. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
    Yuan J, Xu B, Liu BF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb 01; 26(1):47-51. PubMed ID: 15052774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1.
    James S, Moehle K, Renard A, Mueller MS, Vogel D, Zurbriggen R, Pluschke G, Robinson JA.
    Chembiochem; 2006 Dec 01; 7(12):1943-50. PubMed ID: 17068840
    [Abstract] [Full Text] [Related]

  • 19. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL.
    J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640
    [Abstract] [Full Text] [Related]

  • 20. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
    O'Donnell RA, Saul A, Cowman AF, Crabb BS.
    Nat Med; 2000 Jan 01; 6(1):91-5. PubMed ID: 10613831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.